Healthcare provider profile · identity verified

Charles K. Boley

Internal Medicine · WASHINGTON, IL · NPI 1912126640

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	615	179
Amlodipine Besylate	Amlodipine Besylate	432	119
Levothyroxine Sodium	Levothyroxine Sodium	401	115
Lisinopril	Lisinopril	365	109
Losartan Potassium	Losartan Potassium	320	97
Omeprazole	Omeprazole	311	89
Gabapentin	Gabapentin	282	78
Simvastatin	Simvastatin	279	74
Tramadol Hcl	Tramadol Hcl	257	47
Metformin Hcl	Metformin Hcl	247	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	236	42
Alprazolam	Alprazolam	222	29
Lorazepam	Lorazepam	216	41
Montelukast Sodium	Montelukast Sodium	184	62
Pantoprazole Sodium	Pantoprazole Sodium	180	43
Pravastatin Sodium	Pravastatin Sodium	174	52
Hydrochlorothiazide	Hydrochlorothiazide	170	54
Albuterol Sulfate Hfa	Albuterol Sulfate	157	68
Tamsulosin Hcl	Tamsulosin Hcl	148	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	145	46
Metoprolol Succinate	Metoprolol Succinate	142	45
Sertraline Hcl	Sertraline Hcl	141	39
Meloxicam	Meloxicam	138	49
Glimepiride	Glimepiride	136	43
Furosemide	Furosemide	135	39
Carvedilol	Carvedilol	134	39
Zolpidem Tartrate	Zolpidem Tartrate	131	23
Metoprolol Tartrate	Metoprolol Tartrate	129	38
Prednisone	Prednisone	129	82
Jardiance	Empagliflozin	125	31
Cephalexin	Cephalexin	124	78
Venlafaxine Hcl Er	Venlafaxine Hcl	123	33
Clonazepam	Clonazepam	121	23
Pregabalin	Pregabalin	114	24
Rosuvastatin Calcium	Rosuvastatin Calcium	114	39
Alendronate Sodium	Alendronate Sodium	113	30
Valsartan	Valsartan	107	30
Eliquis	Apixaban	101	29
Allopurinol	Allopurinol	99	33
Escitalopram Oxalate	Escitalopram Oxalate	97	34
Trazodone Hcl	Trazodone Hcl	97	36
Famotidine	Famotidine	93	28
Tizanidine Hcl	Tizanidine Hcl	92	36
Ropinirole Hcl	Ropinirole Hcl	89	20
Warfarin Sodium	Warfarin Sodium	89	15
Citalopram Hbr	Citalopram Hydrobromide	79	27
Fenofibrate	Fenofibrate	79	21
Fluticasone Propionate	Fluticasone Propionate	79	31
Atenolol	Atenolol	74	22
Clopidogrel	Clopidogrel Bisulfate	74	22
Januvia	Sitagliptin Phosphate	74	18
Ozempic	Semaglutide	70	16
Fluoxetine Hcl	Fluoxetine Hcl	69	26
Baclofen	Baclofen	65	13
Potassium Chloride	Potassium Chloride	65	18
Hydroxyzine Hcl	Hydroxyzine Hcl	64	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	17
Hydralazine Hcl	Hydralazine Hcl	63	16
Finasteride	Finasteride	60	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	58	19
Duloxetine Hcl	Duloxetine Hcl	56	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	56	17
Sumatriptan Succinate	Sumatriptan Succinate	54	suppressed
Celecoxib	Celecoxib	53	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	suppressed
Paroxetine Hcl	Paroxetine Hcl	53	19
Spironolactone	Spironolactone	50	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	48	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	26
Glipizide	Glipizide	45	11
Amitriptyline Hcl	Amitriptyline Hcl	44	13
Diazepam	Diazepam	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	13
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Xarelto	Rivaroxaban	42	12
Buspirone Hcl	Buspirone Hcl	41	16
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Azithromycin	Azithromycin	37	26
Irbesartan	Irbesartan	37	11
Solifenacin Succinate	Solifenacin Succinate	37	11
Chlorthalidone	Chlorthalidone	35	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	27
Doxycycline Hyclate	Doxycycline Hyclate	34	14
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	13
Lantus	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Memantine Hcl	Memantine Hcl	31	11
Olanzapine	Olanzapine	30	suppressed
Bupropion Xl	Bupropion Hcl	28	16
Metformin Hcl Er	Metformin Hcl	28	suppressed
Topiramate	Topiramate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Amoxicillin	Amoxicillin	26	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	26	14
Fluconazole	Fluconazole	26	18
Clonidine Hcl	Clonidine Hcl	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Ezetimibe	Ezetimibe	24	13
Ibuprofen	Ibuprofen	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Ondansetron Odt	Ondansetron	20	17
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	17
Lactulose	Lactulose	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	13
Nabumetone	Nabumetone	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Ketoconazole	Ketoconazole	16	12
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Scopolamine	Scopolamine	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Etodolac	Etodolac	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Valproic Acid	Valproic Acid	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Estradiol	Estradiol	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nystatin	Nystatin	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error